🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Wishing everyone a very happy International Women's Day! Please join us at the Women in Science Symposium on April 9, 2024 to celebrate some remarkable scientists of the greater Boston area. harvard.zoom.us/webinar/regist…

What an honor being featured at Cancer Discovery with Omer Yilmaz and Nori Goto☺️ Dana-Farber Harvard Medical School Massachusetts Institute of Technology (MIT)

Judith Agudo’s lab is at #EACRTumorEcosystem2024 conference EACR. Come check out our poster #20, 37, 53,60 and 79! Also Monica gives a talk tomorrow!

This is why we made the JEDI mice, a tool for the broad immunology community☺️. So excited to see it helped for these cool findings on resistance of Tuft cells. And that ISCs are killed reproducing our Immunity paper!

Happy to see this special issue on cancer as part of Cell’s #50YearsofCell celebration!

Excited to share that I'll be speaking at the upcoming Nature Conference on Cancer Immunotherapy: From Bench to Bedside and Back! Join us to discuss cutting-edge research in the field. go.nature.com/43Azhj2

Really appreciate this thoughtful piece from Judith Agudo and Shannon McCarthy on our recent Immunity paper! cell.com/immunity/fullt…

Very interesting data from Judith Agudo showing new mechanisms for pan-immune cell evasion specific to metastasis #MRS2024 Metastasis Research Society

So proud of Debolina Ganguly for receiving this prestigious fellowship from Parker Institute for Cancer Immunotherapy to discover how to make breast cancer responsive to immunotherapy. World, get ready, a new super star is rising!

Thrilled to share our latest review with Judith Agudo on the unique immune resistance mechanisms of #CancerStemCells in solid tumors! Explore how these insights are reshaping cancer therapy approaches. #Immunology #CancerResearch #CancerImmunotherapy"

I haven’t posted much since Twitter is X, but I have a good reason today☺️ if you like #cancerstemcells #stemcells and #immunotherapy, this is for you! With partner in crime Phoenix Miao😎 nature.com/articles/s4156…

Happy Halloween! Looking for some spooky reading? 👻 Judith Agudo & Yuxuan (Phoenix) Miao highlight the mechanisms through which normal #stemcells + #cancerstemcells achieve immune resistance (👻), offering insight for developing new cancer therapies. 👻📖👇 bit.ly/40nGGmk

.nature has just published pivotal findings on GD2-CAR T-cell therapy for childhood brain cancer – a novel therapy that recently received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. nature.com/articles/s4158… (1/3)

So honored! Thanks to Cancer Research Institute for this recognition and amazing opportunity

Thanks to the people in my lab, my mentors and collaborators. And the sources of funding that launched my lab New York Stem Cell Foundation Research Institute Dana-Farber News Harvard Medical School Parker Institute for Cancer Immunotherapy and the DoD breast cancer program.

The deadliest cancers don’t just resist treatment, they vanish from the immune system’s view. PICI Investigator Judith Agudo, PhD, Dana-Farber has made it her mission to expose them. This week, that mission was recognized with the 2025 CRI Lloyd J. Old STAR Award, one of

Proud to share Jose M. Adrover’s (new PI The Francis Crick Institute) paper: As a postdoc (Cold Spring Harbor Laboratory/Johns Hopkins Medicine), he found #NETs in necrotic tumors—I shrugged. But he looked closer: NETs block tumor vessel perfusion, causing necrosis, hypoxia, EMT & #Metastasis. nature.com/articles/s4158… @JHU_BDP nature

Stellar postdoc ⁦Debolina Ganguly⁩ and I wrote this spotlight in for a super cool paper on the systemic effects of metatasis in breast cancer. The organ of metastatic disease has a BIG impact! Highly recommended paper in ⁦Cancer Cell⁩ secure-web.cisco.com/1be_LDSMLB9GnZ…

Such an interesting and relevant finding explaining how the seeds of metastasis are gestated in the primary tumor by necrosis! Congrats!